Ask.com
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Geoff Meacham
Recent news which mentions Geoff Meacham
< Previous
1
2
Next >
Moderna Analyst Questions Whether COVID-19 Opportunity Can Support Valuation
December 03, 2020
Tickers
MRNA
Tags
Analyst Ratings
Analyst Color
Benzinga
From
Benzinga
Pfizer Analyst: Coronavirus Vaccine Moving Closer To Emergency Use Authorization
November 09, 2020
Tickers
BNTX
PFE
Tags
Geoff Meacham
vaccine
Coronavirus
From
Benzinga
Biogen Analysts Brace For Favorable Aducanumab Adcom Verdict
November 05, 2020
Tickers
BIIB
Tags
Matthew Harrison
Reiteration
Benzinga
From
Benzinga
Option Trader Bets $2.5M On Biogen After FDA's Favorable Alzheimer's Drug Support
November 04, 2020
Tickers
BIIB
Tags
Markets
Benzinga
Market News
From
Benzinga
BofA On Eli Lilly: Disappointing Q3 Comes In Otherwise Strong 2020
October 27, 2020
Tickers
LLY
Tags
Market News
Reiteration
Price Target
From
Benzinga
Gilead Analysts Trim Expectations After 'Very Unexpected' Adverse FDA Ruling
August 19, 2020
Tickers
ABBV
GILD
GLPG
Tags
General
Cantor Fitzgerald
Biotech
From
Benzinga
Pfizer Analysts See 'Surprisingly Strong' Vaccine Updates In Q2, Question Biopharma's Blockbuster Potential
July 29, 2020
Tickers
MYL
PFE
UBS
Tags
Mizuho Securities
Geoffrey Porges
Carter Gould
From
Benzinga
Pfizer Analyst Says COVID-19-Driven Rally Not Backed By Vaccine Economics
July 23, 2020
Tickers
PFE
Tags
Geoff Meacham
BofA Securities
Market News
From
Benzinga
Moderna Analysts See Positives In Coronavirus Readout As Focus Shifts To Pivotal Phase 3 Study
July 15, 2020
Tickers
BNTX
MRNA
PFE
Tags
Coronavirus
vaccine
News
From
Benzinga
Gilead Analyst Questions Remdesivir's Ultimate Upside As Study Begins For Inhaled Version
June 22, 2020
Tickers
GILD
Tags
BofA Securities
Geoff Meacham
Analyst Color
From
Benzinga
7 High-Risk Stocks For Market Gamblers
May 28, 2020
Tickers
GLNG
GOSS
GWPH
LX
Tags
Long Ideas
Alec Stranahan
Ken Hoexter
From
Benzinga
Bristol-Myers Analyst Says 'Big 7' Pipeline Assets Hold $15B In Peak Sales Potential
May 27, 2020
Tickers
BLUE
BMY
INCY
Tags
INCY
Trading Ideas
Biotech
From
Benzinga
5 Biopharmas Where BofA Would Put Its Money To Work
May 08, 2020
Tickers
ALXN
AMGN
BMRN
BMY
Tags
BofA Securities
VRTX
BMY
From
Benzinga
7 Best-Performing Stocks Of 2020: Buy, Sell Or Hold?
April 26, 2020
Tickers
AMZN
CTXS
GLD
NEM
Tags
Bank of America
Michael Jalonen
NLOK
From
Benzinga
Gilead Analysts Tackle Early Results From Remdesivir Study In COVID-19, Morgan Stanley Says Stock Move Looks Overdone
April 17, 2020
Tickers
GILD
Tags
Jim Birchenough
Yanan Zhu
STAT
From
Benzinga
Gilead Analysts Break Down Remdesivir Data Readout From Compassionate Use
April 13, 2020
Tickers
GILD
Tags
Analyst Ratings
Analyst Color
Wells Fargo Securities
From
Benzinga
Why BofA Has Low Expectations For Gilead's Remdesivir As Potential Coronavirus Treatment
March 20, 2020
Tickers
GILD
Tags
Geoff Meacham
BofA Securities
Market News
From
Benzinga
Why Merck Has Had Underwhelming Start To 2020
February 20, 2020
Tickers
DRG
MRK
Tags
Market News
Benzinga
Reiteration
From
Benzinga
A Preview Of JPMorgan's Healthcare Conference: Focus On Value-Creating Themes, 2020 Expectations
January 10, 2020
Tickers
ALXN
AMGN
BIIB
BMRN
Tags
BMY
Geoff Meacham
Analyst Ratings
From
Benzinga
Seattle Genetics Drug For Difficult-To-Treat Urothelial Cancer Gets Early FDA Nod
December 19, 2019
Tickers
ALPMY
SGEN
Tags
Bank of America
ALPMY
Biotech
From
Benzinga
Bank Of America Initiates United Therapeutics With Bearing Rating, Cites Unclear Growth Outlook
December 03, 2019
Tickers
UTHR
Tags
Geoff Meacham
UTHR
Market News
From
Benzinga
Biogen Analysts Debate About-Face On Aducanumab: 'Path To Market An Uphill Battle'
October 23, 2019
Tickers
BIIB
Tags
Reiteration
Benzinga
Price Target
From
Benzinga
SMid-Cap Biotech: Barclays Downgrades Prothena, Upgrades Achillion
May 21, 2018
Tickers
ACHN
BTAI
CELG
NEWS
Tags
FDA
Upgrades
News
From
Benzinga
BioXcel Could Make 'Unique Play' In Neurology, Oncology, Barclays Says In Bullish Initiation
April 02, 2018
Tickers
BTAI
Tags
BTAI
Geoff Meacham
Barclays
From
Benzinga
Here's What Was Intriguing About Incyte's Q3 Report
November 01, 2017
Tickers
AZN
INCY
NEWS
Tags
Movers
Biotech
BMO Capital
From
Benzinga
Analyst Grows Cautious On Merck's Keytruda After Company Withdraws European Application
October 30, 2017
Tickers
BMY
MRK
RHHBY
Tags
Biotech
Movers
lung cancer
From
Benzinga
Breaking Down Barclays' New Bullish Calls On Biotech
September 07, 2017
Tickers
ALNY
AVXS
BLUE
CRSP
Tags
Biotech
AVXS
Long Ideas
From
Benzinga
2 Names Barclays Is Now Bearish On In Biotech
September 07, 2017
Tickers
CASC
NEWS
ZYME
Tags
Price Target
Reiteration
Benzinga
From
Benzinga
More Than 30% Upside Seen For Vertex Stock On The Heels Of Phase 2 Data
July 19, 2017
Tickers
VRTX
Tags
Lung Drugs
Benzinga
Price Target
From
Benzinga
Zymeworks: Early But Compelling Data, Large Biopharma Partners And A Potential June Catalyst
May 23, 2017
Tickers
CELG
GSK
LLY
MRK
Tags
cancer
Price Target
ZYME
From
Benzinga
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.